Loading
Latest filing published 13 Dec 2019 for Correvio Pharma Corp., €2,289.
No signal scores available.
Robert James Meyer appears in our data through filings on Correvio Pharma Corp. shares, published by SEDI. The record holds 2 filings, for trades running from 25 May 2018 to 13 December 2019.
On the market, this insider has only sold: 1 sale, €2,289 in total. So far in 2019, the count stands at no purchases and 1 sale.
On 13 December 2019 came the latest disclosure, an open-market sale for €2,289 in Correvio Pharma Corp. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations